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Abstract. Acute lymphoblastic leukaemia (ALL) is the most 
frequent childhood cancer and, although it is highly treat-
able, resistance to therapy, toxicity and side effects remain 
challenging. The synthetic glucocorticoid (GC) dexametha-
sone (dex) is commonly used to treat ALL, the main drawback 
of which is the development of resistance to this treatment. The 
aim of the present study was to investigate potential molecular 
circuits mediating resistance and sensitivity to GC-induced 
apoptosis in ALL. The leukaemia cell lines CEM-C7-14, 
CEM-C1-15 and MOLT4 treated with chloroquine (CLQ), 
thapsigargin (TG) and rotenone (ROT) were used to 
explore the roles of autophagy, endoplasmic reticulum (ER) 
stress/unfolded protein response (UPR) and reactive oxygen 
species (ROS) generation in the response to GC treatment. 
ROS levels were associated with increased cell death and 
mitochondrial membrane potential in rotenone-treated CEM 
cells. Autophagy inhibition by CLQ exhibited the strongest 
cytotoxic effect in GC-resistant leukaemia. Autophagy may 
act as a pro-survival mechanism in GC-resistant leukaemia 
since increasing trends in beclin-1 and microtubule-associated 
protein 1 light chain 3α levels were detected in CEM-C1-15 
and MOLT4 cells treated with dex, whereas decreasing trends 
in these autophagy markers were observed in CEM-C7-14 
cells. The intracellular protein levels of the ER stress markers 
glucose-regulated protein (GRP)78 and GRP94 were stimu-
lated by dex only in the GC-sensitive cells, suggesting a role 
of these chaperones in the GC-mediated ALL cell death. 
Increased cell surface levels of GRP94 were recorded in 
CEM-C7-14 cells treated with combination of dex with TG 
compared with those in cells treated with TG alone, whereas 
decreasing trends were observed in CEM-C1-15 cells under 
these conditions. Taken together, the results of the present 
study demonstrated that autophagy may be a pro-survival 
mechanism in GC-resistant leukaemia, and by modulating 
intracellular and surface GRP94 protein levels, dex is involved 
in the regulation of ER stress/UPR-dependent cell death and 
immune surveillance. These observations may be of clinical 
importance if confirmed in patients.
Introduction
Glucocorticoids (GCs) are steroid hormones produced by the 
adrenal glands in response to stress (1). dexamethasone, a 
synthetic GC, has been used to treat patients suffering from 
numerous diseases such as leukaemia, inflammatory bowel 
disease, arthritis, asthma and allergies due to its regulatory 
role in cellular inflammatory responses, which include stimu-
lating immunosuppression, inhibiting cell cycle progression 
and inducing apoptosis (2).
Acute lymphoblastic leukaemia (ALL) is a type of cancer 
of white blood cells that mainly affects children and teen-
agers (3). Several gene mutations and hazardous environmental 
factors (including radiation and toxic chemical exposure) are 
associated with ALL in children (4,5). Factors affecting the 
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development of resistance to ALL treatment include genetic 
variability in xenobiotic metabolism (6), prevalence of a 
GC receptor (GR)β splicing variant (7), upregulation of the 
antiapoptotic Bcl-2 family proteins (8), differential phosphory-
lation of GR in dex-induced apoptosis-resistant vs. sensitive 
ALL cells (9), alterations in dNA repair pathways (10) and cell 
cycle checkpoint defects (11).
Reactive oxygen species (ROS) serve an important role 
in the regulation of GR function (12) and the GC-mediated 
apoptosis in lymphoma cells (13). ROS mediate several cell 
signalling pathways (14) including cell cycle control (15), 
mitochondrial energy metabolism (16) and endoplasmic 
reticulum (ER) stress (17). ER stress is activated in rapidly 
proliferating cancer cells by the accumulation of misfolded 
or unfolded proteins as a consequence of high cellular ROS 
levels (18). The interplay among the mitochondria, ER and ROS 
levels, as well as the connection between ROS-mitochondrial 
membrane potential (MMP)-autophagy and ER stress have 
been extensively studied (19-24).
ER chaperone glucose-regulated protein (GRP)78 and 
GRP94 identify and bind to misfolded proteins, promote 
ER-associated protein degradation and contribute to the 
initiation of the immune response (25,26). Induction of 
ER stress can lead to cell survival or death (27,28). The 
pro-survival outcome of ER stress is in part due to the induc-
tion of its inositol-requiring enzyme 1 arm, which activates 
Jun N-terminal kinase (JNK) (29) and stimulates Bcl-2 
phosphorylation to regulate autophagy through the modula-
tion of the beclin-1 function and gene expression (30). In 
addition, diverse ER stress inducing conditions that involve 
the PKR-like endoplasmic reticulum kinase pathway and 
eukaryotic initiation factor 2α phosphorylation regulate 
the conversion of the pro-survival autophagy mediating 
microtubule-associated protein 1 light chain 3α (LC3) (31). 
However, if ER stress persists and the refolding of unfolded 
proteins is not resolved, unfolded protein response (UPR) 
ensues; UPR is primarily a pro-survival process, but prolonged 
stress may result in the induction of cell death (27,28,32) via 
stimulation of CCAAT/enhancer-binding protein homologous 
protein (CHOP) (33).
The communication between the mitochondria and 
the endoplasmic reticulum (34) and the regulation of Ca2+ 
homeostasis by the integration of the function of Bcl-2 family 
members (35), endoplasmic reticulum chaperones (36) and 
their adjustment to the cellular redox state (37) is another 
mechanism controlling the pro-survival and pro-death 
pathways. Our bioinformatics analysis of Ca2+ signalling and 
autophagy pathways indicated that out of the 11,320 genes 
associated with Ca2+ signalling and 5,207 associated with 
autophagy, 1,109 genes are associated with both path-
ways (unpublished data). These genes include the inositol 
1,4,5-trisphosphate receptor, ryanodine receptor, mitochon-
drial calcium uniporter, two pore segment channels, transient 
receptor potential channels, store-operated calcium channels, 
GRP78 and GRP94, the functions of which have been previ-
ously described (38-41).
T-cell ALL (T-ALL) and B-ALL differ in terms of 
prognostic factors and risk classification such as age, white 
blood cell count, hyperdiploidy and the presence of translo-
cations (42,43). Similar therapeutic schemes are used for the 
treatment of T‑ALL and B‑ALL, although significant toxicity 
associated with chemotherapy has been reported for B-ALL, 
as adults do not always benefit from therapeutic schemes used 
for paediatric patients (42,43).
The present study aimed to investigate the molecular 
mechanisms mediating the resistance of T-ALL cells to dex 
treatment. Established T-ALL CEM-C7-14 and CEM-C1-15 
cell lines, which are sensitive and resistant, respectively, to 
dex-induced apoptosis, were used to determine the crosstalk 
of multiple pathways involved in the response of T-ALL cells 
to chemotherapy. In particular, the potential consequences of 
the differential ROS detoxification in the T‑ALL cells resistant 
or sensitive to dex-induced apoptosis (44) and the ensuing 
changes in ER stress, autophagy and MMP were investigated. 
Emphasis was placed on understanding how changes in oxida-
tive stress may be translated through autophagy, ER stress, 
UPR and the function of the ER chaperone proteins GRP94 
and GRP78 to GC-mediated cell death.
Materials and methods
Cell culture. A previously established T-ALL in vitro system 
to study resistance to steroid response, consisting of the 
CEM-C1-15 and CEM-C7-14 cell lines (45) derived from 
lymphoblastic cells of a patient with ALL (46), was used in the 
present study. The T-ALL MOLT4 (cat. no. TCP-1010; ATCC) 
cells were used to explore whether the conclusions derived 
from the experiments using CEM cells were relevant to other 
types of T-ALL cells. Cells were cultured with 5% CO2 at 
37˚C in RPMI‑1640 medium (Sigma‑Aldrich; Merck KGaA) 
supplemented with 10% foetal bovine serum (Sigma-Aldrich; 
Merck KGaA), 1% penicillin/streptomycin (Lonza Group, Ltd.) 
and 1% L-glutamine (Lonza Group, Ltd.). dextran-coated 
charcoal-treated serum (Sigma-Aldrich; Merck KGaA) was 
used in all experiments prior to the addition of drugs.
Drugs. The concentration of 1 µM dexamethasone (dex; 
Enzo Life Sciences, Inc.) was chosen for the treatment of 
the cells at the indicated time-points based on previous 
studies (47-49). The optimal treatment duration to observe 
differential effects of glucocorticoids in the sensitive vs. resis-
tant cells was 48 h (49). The concentrations of chloroquine 
(CLQ; 100 µM; Sigma-Aldrich; Merck KGaA), thapsigargin 
(TG; 20 µM; Sigma-Aldrich; Merck KGaA) and rotenone 
(ROT; 20 µM; Sigma-Aldrich; Merck KGaA) were determined 
through optimization of experimental conditions (data not 
shown) and literature search (47,48). All drugs were dissolved 
in dimethyl sulfoxide (chloroquine, thapsigargin and rotenone) 
or ethanol (dexamethasone) and used as indicated. The control 
groups were treated with dMSO.
Cell proliferation assay. CEM-C1-15, CEM-C7-14 and MOLT4 
cells (1x106 cells/ml) were seeded in 96-well plates prior to 
drug treatment for 48 h at 37˚C. Once the drug incubation was 
complete, 20 µl CellTiter 96 Aqueous MTS reagent working 
solution (cat. no. G1112; Promega Corporation) was added 
to the wells and incubated at 37˚C for 4 h. The absorbance 
of the samples was read at 490 nm using a microplate reader 
(Multiskan Ascent Thermo Labsystems 354 with Ascent soft-
ware version 2.6) with 690 nm background compensation.
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MMP assay. CEM-C1-15, CEM-C7-14 and MOLT4 cells 
(1x106 cells/ml) were seeded in 6-well plates prior to combina-
tion treatments (dex, CLQ, TG, ROT, dex + CLQ, dex + TG 
or Dex + ROT) for 48 h at 37˚C. Subsequently, the cells were 
suspended in 1 ml medium, and 6.25 µl solution 7 (JC-1 dye; 
ChemoMetec A/S) was added to each sample, followed by 
20‑min incubation at 37˚C. The stained cells were centrifuged 
at 400 x g for 5 min at room temperature, the supernatant was 
removed, and the samples were washed twice with PBS. The 
pellets were resuspended in 250 µl solution 8 (dAPI), and the 
samples were analysed using a NucleoCounter NC-3000 with 
NucleoView software version 1 (ChemoMetec A/S).
ROS assay. A carboxy-H2dCAdA probe (Invitrogen; Thermo 
Fisher Scientific, Inc.) was used to detect ROS generated in 
ALL cells treated with the aforementioned drugs. A probe 
containing 2',7'-dichlorofluorescein and calcein was used 
to detect oxidation by determination of the increase in fluo-
rescence signalling using a flow cytometer, with excitation 
sources and filters for FITC channel. CEM‑C1‑15, CEM‑C7‑14 
and MOLT4 cells (1x106 cells/ml) were seeded in 6-well 
plates before combination treatments (dex, CLQ, TG, ROT, 
Dex + CLQ, Dex + TG or Dex + ROT) for 24 h at 37˚C. The 
cells were centrifuged at 753 x g for 3 min at 4˚C, and the 
supernatants were discarded. The cell pellets were resuspended 
in 1 ml cold PBS and centrifuged at 753 x g for 3 min at 4˚C. 
Carboxy-H2dCFdA dye (100 µl) was added to the pellets, and 
the cells were incubated for 30‑60 min at 37˚C with 5% CO2 
in the dark. The dye was discarded by centrifuging the pellets 
at 753 x g for 3 min at 4˚C. The cells were washed with cold 
PBS and analysed by flow cytometry (BD FACSVerse™ with 
Bd FACSuite software version 1.0; Bd Biosciences) using the 
FITC channel.
Immunoblotting. CEM-C1-15, CEM-C7-14 and MOLT4 cells 
treated with dex, CLQ, TG or ROT alone or a combination 
of dex with CLQ, TG or ROT were harvested and lysed with 
RIPA buffer (cat. no. R0278; Sigma-Aldrich; Merck KGaA). 
Protein concentration was determined using the Bradford 
assay, and 40 µg of total protein lysates were subjected to 
12% sodium dodecyl sulphate polyacrylamide gel electropho-
resis and transferred to a polyvinylidene difluoride membrane 
(EMd Millipore). Following blocking with 5% skimmed milk 
in 1X PBS for 1 h at room temperature, the membrane was 
incubated with rabbit polyclonal anti-LC3A/B (cat. no. 4108; 
1:1,000; Cell Signalling Technology, Inc.), rabbit mono-
clonal anti-beclin-1 (cat. no. 3495; 1:1,000; Cell Signalling 
Technology, Inc.), mouse monoclonal anti-GRP78 (cat. 
no. sc-376768; 1:500; Santa Cruz Biotechnology, Inc.), mouse 
monoclonal anti-GRP94 (cat. no. sc-53929; 1:500; Santa Cruz 
Biotechnology, Inc.) and rabbit polyclonal anti-β-actin (cat. 
no. ab8227; 1:2,000; Abcam) antibodies at 4˚C overnight, 
followed by 1‑h incubation at 4˚C with secondary antibodies 
conjugated with horseradish peroxidase (anti-rabbit cat. 
no. NA934; anti-mouse cat. no. NA931; 1:4,000; Cytiva). 
Protein bands were detected using an enhanced chemilu-
minescence solution (Thermo Fisher Scientific, Inc.) and an 
X‑ray film (Fujifilm Corporation). The band intensities were 
estimated using ImageJ version 1.51 (National Institutes 
of Health).
Reverse transcription‑quantitative PCR (RT‑qPCR). Total RNAs 
were isolated from 3x106 CEM-C7-14, CEM-C1-15 and MOLT4 
cells using a High Pure RNA Isolation kit (Roche Molecular 
Systems, Inc.) and the concentration of the total RNA for each 
sample was measured using a NanoDrop™ spectrophotometer 
(Thermo Fisher Scientific, Inc.). Complementary dNA was 
reverse‑transcribed using a High‑Capacity RNA‑to‑cDNA™ kit 
(Applied Biosystems; Thermo Fisher Scientific, Inc.) at 37˚C for 
1 h. QPCR was performed using GRP94, GRP78 and RPL19 
(internal control) primers (Eurofins Scientific) mixed with 
SensiFAST SYBR® No-ROX kit (Bioline) as previously 
described (50,51). The primer sequences were as follows: GRP78 
forward, 5'-TGCCGTTCAAGGTGGTTG-3' and reverse, 5'-CCA 
AATAAGCCTCAGCGG-3'; GRP94 forward, 5'-CTGGGTCCA 
GCAGAAAAGAG-3' and reverse, 5'-CACTCCTTCCTTGGC 
AACAT-3'; RPL19 forward, 5'-ATGTATCACAGCCTGTAC 
CTG-3' and reverse, 5'-TTCTTGGTCTCTTCCTCCTTG-3'. The 
data were analysed using the 2-ΔΔCq method (52).
Cell surface staining assay. CEM-C1-15, CEM-C7-14 and 
MOLT4 cells (1x106 cells/ml) were seeded in 6-well plates and 
combination treatments (dex, CLQ, TG, ROT, dex + CLQ, 
Dx + TG or Dex + ROT) were applied for 48 h at 37˚C. 
Cells were washed with cold (4˚C) 2% FBS in PBS before 
incubation with an anti-GRP94 antibody (9G10) conjugated 
to Alexa Fluor® 488 (cat. no. sc-32249 AF488; Santa Cruz 
Biotechnology, Inc.) for 2 h at 4˚C. The cell pellet was fixed 
with 4% paraformaldehyde in FBS/PBS at 4˚C for 15 min, 
washed twice with 500 µl PBS (4˚C) and flow cytometry 
(BD FACSVerse™ with BD FACSuite software) was used to 
detect surface GRP94 fluorescence intensity.
Statistical analysis. data are presented as the mean ± standard 
error of the mean of data from three independent experiments. 
Statistical analysis was conducted using GraphPad Prism 8 
Software (GraphPad Software, Inc.). One-way ANOVA and 
dunnett's post hoc test were used for multiple comparisons. 
P<0.05 was considered to indicate a statistically significant 
difference.
Results
Cytotoxic effects of individual and combined drug treatments. 
The present study analysed the autophagy pathway using CLQ, 
which is an autophagy inhibitor (53), ER stress using TG, 
which regulates Ca2+ homeostasis and activates ER stress (54), 
and ROS generation using ROT, which induces mitochondrial 
oxidative stress by inhibiting complex I of the mitochondrial 
respiratory chain and modulates autophagy (55) in GC-treated 
ALL cells. Time course and drug concentration studies were 
performed to determine the optimal experimental conditions 
(data not shown).
To assess ALL cell viability upon treatment with dex, 
CLQ, TG and ROT alone or in combinations, MTS assay was 
performed in CEM-C7-14, CEM-C1-15 and MOLT4 cells 
treated with dex alone or in combination with CLQ, TG or 
ROT (Fig. 1). dex induced a less pronounced reduction in 
CEM-C1-15 cell viability compared with that of the CEM-C7-14 
cells, whereas the viability of MOLT4 cells treated with dex 
was 50% of that in untreated cells (Fig. 1). CLQ, TG and ROT 
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alone or in combination with dex inhibited cell proliferation in 
all cells compared with that of untreated cells (Fig. 1). These 
results suggest that GCs alone mostly affected CEM-C7-14 
cells, whereas CEM-C1-15 cells weakly responded to dex, 
indicating a resistant phenotype, and MOLT4 cells appeared to 
exhibit a stronger response to dex compared with CEM-C1-15 
cells, but weaker compared with CEM-C7-14 cells (Fig. 1). A 
potent cytotoxic effect was observed in the CEM-C1-15 cells 
treated with CLQ alone or in combination with dex (Fig. 1B). 
These results suggested that dex treatment, autophagy inhi-
bition, ER stress and induction of ROS generation exerted 
different cytotoxic effects in the studied ALL cells.
ROS generation in ALL cells treated with Dex, CLQ, TG 
and ROT alone or in combination. To investigate the 
potential involvement of ROS generation in response to GC 
treatment of ALL cells, CEM-C1-15, CEM-C7-14 and MOLT4 
cells were treated with dex, CLQ, TG or ROT alone or in 
combination, and the ROS levels were determined by flow 
cytometry. No significant difference in the ROS levels was 
observed in dex-treated compared with untreated CEM-C1-15 
cells (Figs. 2B and S1), whereas significantly decreased the 
ROS levels were detected in dex-treated compared with 
untreated CEM‑C7‑14 cells (Figs. 2A and S1). No significant 
effect of dex treatment on the ROS levels in MOLT4 cells 
was observed (Figs. 2C and S1). CLQ alone or in combination 
with dex slightly decreased the ROS levels in CEM-C1-15 
cells, although the changes were not statistically signifi-
cant (Figs. 2B and S1). No significant effects of CLQ alone or 
in combination with dex on the ROS levels of CEM-C7-14 and 
MOLT4 cells were observed (Figs. 2A, C and S1). Treatment 
of CEM-C7-14 cells with TG alone (Figs. 2A and S1) and 
of MOLT4 cells with TG alone or in combination with 
Dex (Figs. 2C and S1) significantly decreased ROS genera-
tion. By contrast, ROT alone or in combination with dex 
substantially increased ROS production in CEM-C1-15 and 
CEM-C7-14 cells compared with that in the respective untreated 
cells (Figs. 2A and B and S1). This effect appeared to be more 
pronounced in CEM-C7-14 compared with CEM-C1-15 cells. 
The ROS levels were not affected in MOLT4 cells by ROT 
alone, whereas ROT‑Dex co‑treatment resulted in a significant 
decrease of ROS generation in these cells (Figs. 2C and S1).
In summary, lower ROS levels were recorded in dex- 
and TG-treated CEM-C7-14 cells compared with those in 
untreated cells, whereas CLQ had no effect. In MOLT4 cells, 
TG reduced the ROS levels. ROT increased the ROS levels 
Figure 1. Cytotoxic effects of dex and anticancer agents on ALL cells. dex (10 µM), CLQ (100 µM), TG (20 µM) and ROT (20 µM) were used to treat 
(A) CEM-C7-14, (B) CEM-C1-15 and (C) MOLT4 cells for 48 h individually or in combination to assess the cell viability using MTS assay. data are presented 
as the mean ± SEM. *P<0.05, **P<0.01, ***P<0.001 vs. untreated control. ALL, acute lymphoblastic leukaemia; dex, dexamethasone; CLQ, chloroquine; TG, 
thapsigargin; ROT, rotenone.
Figure 2. Effects of dex and anticancer agents on ROS production. The relative ROS intensity was recorded in (A) CEM-C7-14, (B) CEM-C1-15 and (C) MOLT4 
cells using a 2’,7’‑dichlorofluorescein probe and flow cytometry. Cells were treated with 1 µM Dex, 50 µM CLQ, 10 µM TG and 10 µM ROT as indicated. 
data are presented as the mean ± SEM. *P<0.05, **P<0.01, ***P<0.001 vs. untreated control. dex, dexamethasone; CLQ, chloroquine; TG, thapsigargin; ROT, 
rotenone; ROS, reactive oxygen species.
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in CEM-C7-14 and CEM-C1-15 cells compared with those in 
the respective untreated cells, whereas it did not lead to an 
increase in the ROS levels in MOLT4 cells.
MMP in ALL cells treated with Dex, CLQ, TG and ROT 
alone or in combination. Considering the differential 
effects of individual dex, CLQ, TG and ROT treatment on 
ROS generation in CEM-C7-14, CEM-C1-15 and MOLT4 
cells, and the interplay between mitochondrial function and 
cellular ROS levels (56), the effects of dex, CLQ, TG and 
ROT alone or combined with dex on the MMP of ALL 
cells were investigated. dex treatment alone significantly 
increased the MMP in CEM-C7-14 cells compared with that 
in untreated cells (Figs. 3A and S2A), whereas limited effects 
were observed in CEM-C1-15 and MOLT4 cells under the 
same conditions (Figs. 3B, C, S2B and C). Increased MMP 
was observed in the MOLT4 cell line treated with CLQ alone 
compared with that in untreated cells (Figs. 3C and S2C), as 
well as in CEM-C7-14 and CEM-C1-15 cells treated with the 
combination of CLQ and dex compared with that in untreated 
cells (Figs. 3A, B, S2A and B). TG and ROT treatment alone 
increased MMP in CEM-C7-14 and CEM-C1-15 cells compared 
with that in untreated cells (Figs. 3A, B, S2A and B). Increased 
MMP was also observed in all studied cell lines treated with 
ROT or the combination of ROT and dex compared with that 
in untreated cells (Figs. 3, S2A, B and C).
It appeared that most of the tested treatments increased 
MMP in CEM-C7-14 and CEM-C1-15 cells with higher 
effects in CEM-C7-14 cells, whereas in MOLT4 cells, CLQ 
and ROT increased MMP compared with that in untreated 
cells. Addition of dex to TG-treated cells abolished the MMP 
increase in CEM-C7-14 and CEM-C1-15 cells.
Effects of individual and combined drug treatments on 
protein expression levels in ALL cells. To analyse the role of 
autophagy and ER stress in GC-mediated ALL cell survival 
or death, the protein levels of autophagy (beclin-1 and 
LC3-II) and ER stress (GRP78 and GRP94) indicators were 
analysed by western blotting in CEM-C7-14, CEM-C1-15 and 
MOLT4 cells (Figs. 4, S3A, B and C). A small but significant 
increase in beclin-1 protein levels, which mark the early 
stages of autophagy, was observed in TG-treated MOLT4 cells 
compared with untreated cells (Figs. 4A and S3B), whereas a 
decrease was observed in ROT and dex co-treated CEM-C1-15 
cells (Figs. 4A and S3C). LC3-II, is an indicator of late-stage 
autophagy, was increased in CEM-C1-15 and MOLT4 cells, 
but marginally decreased in CEM-C7-14 cells treated with 
dex alone compared with the respective untreated cells 
(Figs. 4B, S3A, B and C). Higher LC3-II protein levels were 
observed in cells treated with CLQ and TG alone and in combi-
nation with dex in all tested cell lines (Figs. 4B and S3B). No 
significant effects on LC3‑II were observed in ROT‑treated 
CEM-C7-14 and MOLT4 cells, whereas in CEM-C1-15 cells, 
downregulation of LC3-II was observed compared with 
untreated cells (Figs. 4B and S3C).
Dex treatment alone significantly increased GRP94 and 
GRP78 protein levels in CEM-C7-14 cells compared with those 
in untreated cells and there were no changes in CEM-C1-15 
and MOLT4 cells (Figs. 4C, D and S3). A significant increase 
of GRP94 protein levels was also evident in CEM-C7-14 cells 
co-treated with dex and CLQ or TG compared with those in 
untreated cells (Figs. 4C and S3A and B). In CEM-C1-15 cells 
treated with CLQ alone or with a combination of dex and ROT 
and in MOLT4 cells treated with TG alone, increased levels of 
GRP94 were observed compared with those in untreated cells 
(Figs. 4C, S3A, B and C). Increased GRP78 protein levels were 
observed in CEM-C7-14 cells treated with dex alone, ROT 
alone or a combination of CLQ or TG with dex compared 
with those in untreated cells (Figs. 4d, S3A, B and C). The 
most substantial increase in both chaperone cellular levels was 
observed in GC-sensitive ALL cells (CEM-C7-14) co-treated 
with dex and TG (Fig. S3B).
To determine whether the changes in GRP94 and GRP78 
protein levels were at the gene expression level, the effects 
of dex on GRP94 and GRP78 gene expression were studied 
using RT-qPCR. GRP94 and GRP78 mRNA levels were not 
affected in dex-treated CEM cells, whereas decreased GRP94 
mRNA levels were observed in MOLT4 cells compared with 
those in untreated cells (Fig. S4).
To summarise, compared with those in untreated cells, 
the levels of GRP94 and GRP78 markers of ER stress were 
increased in dex-treated CEM-C7-14 cells, whereas the 
autophagy marker LC3-II was decreased in CEM-C7-14 and 
increased in CEM-C1-15 and MOLT4 cells.
Figure 3. Effects of dex and anticancer agents on MMP alteration. MMP was measured (A) in CEM-C7-14, (B) CEM-C1-15 and (C) MOLT4 cells treated 
with 1 µM dex, 50 µM CLQ, 10 µM TG and 10 µM ROT for 48 h and using the JC-1 dye. data are presented as the mean ± SEM. *P<0.05, **P<0.01, 
***P<0.001 vs. untreated control. dex, dexamethasone; CLQ, chloroquine; TG, thapsigargin; ROT, rotenone; MMP, mitochondrial membrane potential.
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GRP94 surface expression in ALL. The extracellular surface 
GRP94 levels in ALL cells treated with dex, CLQ, TG and 
ROT alone or in combination were investigated. TG and 
ROT treatment alone increased GRP94 surface levels in both 
the GC-sensitive and resistant CEM cells compared with 
those in the untreated control group (Figs. 5, S5A and B). 
Combination of TG and ROT with dex increased the GRP94 
surface levels in the CEM-C7-14 and CEM-C1-15 cells 
compared with those in untreated cells (Figs. 5, S5A and B). 
TG-dex co-treatment exhibited a st rong effect in 
CEM-C7-14 cells, whereas ROT effects individually or in 
combination with dex was prominent in CEM-C1-15 cells. 
Surface GRP94 levels did not change in MOLT4 cells in any 
conditions (Figs. 5 and S5C).
These results suggested that GC or CLQ treatment alone 
did not significantly affect GRP94 surface location, whereas 
ER stress and ROS generation increased the GRP94 surface 
levels in CEM-C7-14 and CEM-C1-15 cells. dex potentiated 
the effects of TG in CEM-C7-14 cells and inhibited TG effect 
in CEM-C1-15 cells, and ROT displayed more potent effects 
in the GC-resistant CEM-C1-15 cells compared with those in 
CEM-C7-14 cells.
Figure 5. GRP94 surface expression levels on ALL cells. The CEM-C7-14 (white bars), CEM-C1-15 (black bars) and MOLT4 (grey bars) cells stained posi-
tive for GRP94 surface expression were detected by flow cytometry after 48‑h treatments with 1 µM Dex, 50 µM CLQ, 10 µM TG and 10 µM ROT alone 
or in combination as indicated. data are presented as the mean ± SEM. *P<0.05, **P<0.01 vs. untreated control. ALL, acute lymphoblastic leukaemia; dex, 
dexamethasone; CLQ, chloroquine; TG, thapsigargin; ROT, rotenone; GRP, glucose-regulated protein.
Figure 4. Protein expression in ALL following combination drug treatments. The protein levels of (A) beclin-1, (B) LC3-II, (C) GRP94 and (d) GRP78 were 
detected by western blotting in CEM-C7-14 (white bars), CEM-C1-15 (black bars) and MOLT4 (grey bars) cells after 48-h incubation with 1 µM dex, 50 µM 
CLQ, 10 µM TG and 10 µM ROT individually or in combination as indicated. The values were normalised to the corresponding actin loading control. data 
are presented as the mean ± SEM. *P<0.05, **P<0.01, ***P<0.001 vs. untreated control. ALL, acute lymphoblastic leukaemia; dex, dexamethasone; CLQ, 
chloroquine; TG, thapsigargin; ROT, rotenone; LC3-II, microtubule-associated protein 1 light chain 3α; GRP, glucose-regulated protein.
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Discussion
The main therapeutic options for patients with ALL are based 
on treatment with GC hormones, which exert their effects by 
inducing apoptosis of malignant T cells through intrinsic and 
extrinsic pathways (50). As a result of greater potency and 
CNS penetration, dexamethasone is frequently selected as the 
treatment of choice for T-ALL (42,43). A major drawback of 
GC treatment is the development of resistance (57). Inhibition 
of cell death and resistance of T cells to GC treatment has 
been attributed to a variety of molecular mechanisms (58), 
including autophagy (59). Autophagy is important for numerous 
physiological and pathological processes and for the function of 
immune system cells from antigen presentation to inflammatory 
signalling and metabolism (60). Various forms of autophagy 
triggered by distinct stimuli, such as ER stress, Ca2+ homeostasis 
and ROS signalling, control T cell survival (61). Since ER stress 
and UPR contribute to inflammatory signalling by activating 
a number of stress-responsive kinases including ERK, p38 
mitogen-activated protein kinase and JNK (62), which have been 
demonstrated to induce GR post‑translational modifications that 
affect its transcriptional activity (51,63,64), it is possible that 
these mechanisms lead to resistance to GC-induced apoptosis in 
ALL by modulating the function of the GR (51,62-64).
In the present study, dex, CLQ, TG and ROT were used to 
treat GC-sensitive (CEM-C7-14) and resistant (CEM-C1-15) 
as well as MOLT4 cells to investigate the roles of autophagy, 
ER stress, UPR and oxidative stress in the mechanisms of 
GC-induced ALL apoptosis, development of resistance and 
potential ways to overcome it. Characterisation of the CEM 
genetic alterations has been reported in the literature (47-49,65). 
Shedding light on this topic may facilitate the improvement 
of the current therapeutics and the development of novel 
anti-ALL treatments.
Autophagy has been reported to promote or suppress 
the proliferation of ALL cells (66). Recent studies have 
indicated that autophagy and ROS may serve a significant 
role in the determination of effects of GC treatment on ALL 
cells (59,67-69). Treatment of the GC-sensitive and resistant 
leukaemia cells with the autophagy inhibitor CLQ reduced 
their viability, and this reagent appeared to be the most effec-
tive in inducing GC‑ resistant ALL cell death. These findings 
suggested that autophagy may be involved in the GR-induced 
cell death (70) and it may facilitate the activation of the 
pro-survival mechanisms in GC-resistant cells, which was 
in agreement with previous studies indicating cytoprotective 
effects of autophagy in T-ALL cells treated with PI3K/mTOR 
or Akt inhibitors (71).
Accumulating evidence indicates an association between 
ROS generation and autophagy with alterations in the mito-
chondrial permeability transition pore (MPTP), ER stress, 
Ca2+ homeostasis and apoptosis (20,72). In addition, the mito-
chondria-ER contact sites regulate immune cell survival/death 
decisions (73). The results of the present study demonstrated 
that GR-induced apoptosis in GC-sensitive ALL cells was 
associated with the increase in MMP disruption, suggesting 
that the regulation of the MPTP opening is a potential 
mechanism underlying the effects of dex in the determina-
tion of ALL cell survival or death. A previous studies has 
demonstrated that spliced x-box binding protein 1 and GRP78 
are upregulated in Ph+ leukaemia cell lines, leading to the 
activation of the UPR-related apoptosis protein CHOP (74). 
Although various cell type- and treatment duration-dependent 
effects were observed in the present study, definite conclu-
sions regarding the chronological order of the occurrence of 
ROS generation, ER stress and autophagy in dex-induced 
apoptosis-resistant vs. sensitive T-ALL cells cannot be drawn 
based on the experimental approaches used.
In the present study, dex treatment of the GC-sensitive 
cells, but not the GC-resistant cells, led to increased expression 
levels of GRP78 and GRP94 compared with those in untreated 
cells. High GRP expression has been reported to be associ-
ated with cancer cell aggressiveness and metastatic potential 
in several cancer cell lines such as breast carcinoma, prostate 
adenocarcinoma, liver cancer, colorectal cancer, multiple 
myeloma and leukaemia (75). The results of the present 
study demonstrated that dex stimulated GRP78 and GRP94 
expression in GC-sensitive cells in a transcription-independent 
manner. GRP78 inhibits the translocation function on the 
ER membrane, preventing Ca2+ leakage from the ER to the 
cytoplasm (36) and altering the Ca2+-dependent mitochondrial 
apoptosis (73), which may explain the differential response of 
CEM-C7-14 and CEM-C1-15 cells to dex treatment.
The results of the present study that indicated that dex 
induced GRP94 expression in the GC-sensitive ALL cells were 
unexpected, as GRP78 and GRP94 upregulation is associated 
with a negative prognosis in various types of cancer such as 
prostate, oesophageal, gastric, breast and lung cancer (75). The 
role of GRP94 in the stimulation of T cells and regulation of 
immunity as well as induction of antitumour activity has been 
indicated (76). Surface localization of GRP94 is an important 
level of control of its function (77-79). In the present study, GCs 
induced the intracellular protein levels of these chaperones, but 
did not affect the mRNA or surface GRP94 expression levels; 
however, when dex was combined with TG, the GRP94 surface 
expression increased in the GC-sensitive cells and decreased 
in the GC-resistant cells, suggesting that selective mechanisms 
determining the subcellular location of GRP94 may operate 
in the GC-resistant and sensitive cells. The molecular mecha-
nisms involved in the regulation of resistance or sensitivity of 
ALL cells to dex treatment through the induction of GRP94 
are novel observations described in the present manuscript. In 
addition, considering the role of GRP proteins in the process 
of immunosurveillance and immune response (26,80), it may 
be speculated that the changes occurring in the GRP levels 
and localization may directly or indirectly affect the immune 
response to the drug treatment. Therefore, it is possible that by 
differentially modulating the GRP94 surface levels in resistant 
and sensitive ALL cells co-treated with dex and TG or ROT, 
GCs facilitate their recognition and elimination by the immune 
system, highlighting the need for further investigation of the 
secreted GRP levels and their effects on the immune system.
Limitations of the present study include the lack of an addi-
tional control cell line to consolidate the findings, and images 
demonstrating the morphology of the cells in culture were not 
provided. The effects of dex alone or in combination with TG 
or ROT in B-ALL cells were not investigated, which should be 
addressed in the future. Of note, in vivo and in vitro drug doses 
are not comparable (81). Future in vivo studies with patients 
are required to verify the findings of the present study.
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In conclusion, the drugs tested in the present study decreased 
the viability of CEM-C7-14 cells via mitochondria-ER commu-
nication mechanisms, upregulating GRP78 and GRP94 and 
inducing cell death (Fig. 6). These observations, if confirmed in 
clinical settings, may be used to increase the visibility of ALL 
cells to the immune system for the stratification of patients for 
immunotherapy and increased therapeutic success.
Acknowledgements
Part of this study was included in S. Sudsaward's Phd thesis.
Funding
This study was supported by the Royal Thai Government 
Scholarships, Ministry of Science and Technology, Thailand 
(to SS), the Staff development Fund, Naresuan University (SK) 
the Thailand Research Fund (TRF; grant no. IRG5980006 to PY), 
the TRF-International Research Network (grant no. IRN58w001 
to PY), the Siriraj Research Fund (grant no. R016034008 to PY), 
the Siriraj Chalermprakiat Grant (to PY and TL) and a TRF-Royal 
Golden Jubilee Ph.d. Scholarship (no. PHd/0044/2556 to CT).
Availability of data and materials
All data generated or analysed during this study are included 
in this published article.
Authors' contributions
SS planned and performed experiments, analysed the results 
and prepared the draft of the manuscript. SK, CT and AO 
performed the experiments, analysed the results and reviewed 
the manuscript. TL, PTY and LM analysed the results and 
reviewed the manuscript. MKd and Cd formulated the 
hypothesis and supervised the study, interpreted the results 
and prepared the manuscript. All authors read and approved 
the final manuscript.
Ethics approval and consent to participate
Not applicable.
Patient consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
References
 1. Arlt w and Stewart PM: Adrenal corticosteroid biosynthesis, 
metabolism, and action.  Endocrinol Metab Clin North Am 34: 
293-313, 2005.
Figure 6. Summary of the hypothetical GC-mediated pathways leading to T-ALL cell death. GCs induce cell death in the sensitive CEM-C7-14 cells by 
inducing mitochondria and ER stress-mediated cell death through the induction of Bim and GRPs, respectively. Alteration of mitochondrial membrane potential 
may be involved in mitochondria-mediated apoptosis induced by ROT. GRP activation triggered by TG possibly regulates ER stress-mediated cell death. 
CLQ-mediated inhibition of autophagy in CEM-C7-14 and CEM-C1-15 or induction of ROS generation by ROT in these cells may stimulate other types of 
cell death (e.g. necroptosis). ER stress and induction of ROS generation affect GRP94 plasma membrane relocalisation; the magnitude of this effect is differ-
entially regulated in CEM-C7-14 and CEM-C1-15 and may be hormone-dependent. T-ALL, T-cell acute lymphoblastic leukaemia; GCs, glucocorticoids; GRP, 
glucose-regulated protein; dex, dexamethasone; CLQ, chloroquine; TG, thapsigargin; ROT, rotenone; ROS, reactive oxygen species; ER, endoplasmic reticulum.
INTERNATIONAL JOURNAL OF ONCOLOGY  00:  IJO-244781-SUdSAwARd,  0000 9
 2. Galon J, Franchimont d, Hiroi N, Frey G, Boettner A, 
Ehrhart-Bornstein M, O'Shea JJ, Chrousos GP and Bornstein SR: 
Gene profiling reveals unknown enhancing and suppressive actions 
of glucocorticoids on immune cells. FASEB J 16: 61-71, 2002. 
 3. Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert dL, 
O'Leary M, Smith FO and Reaman GH: Outcomes for children 
and adolescents with cancer: Challenges for the twenty-first 
century. J Clin Oncol 28: 2625-2634, 2010. 
 4. Greaves M: Infection, immune responses and the aetiology of 
childhood leukaemia. Nat Rev Cancer 6: 193-203, 2006. 
 5. Greaves MF and wiemels J: Origins of chromosome translo-
cations in childhood leukaemia. Nat Rev Cancer 3: 639-649, 
2003. 
 6. Krajinovic M, Sinnett H, Richer C, Labuda d and Sinnett d: 
Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the 
susceptibility to childhood acute lymphoblastic leukemia. Int J 
Cancer 97: 230-236, 2002. 
 7. webster JC, Oakley RH, Jewell CM and Cidlowski JA: 
Proinflammatory cytokines regulate human glucocorticoid 
receptor gene expression and lead to the accumulation of the 
dominant negative beta isoform: A mechanism for the generation 
of glucocorticoid resistance. Proc Natl Acad Sci USA 98: 
6865-6870, 2001. 
 8. Alves NL, derks IA, Berk E, Spijker R, van Lier RA and 
Eldering E: The Noxa/Mcl-1 axis regulates susceptibility 
to apoptosis under glucose limitation in dividing T cells. 
Immunity 24: 703-716, 2006. 
 9. Berrou I, demonacos C and Krstic-demonacos M: Molecular 
mechanisms conferring resistance/sensitivity to glucocor-
ticoid-induced apoptosis. In: Glucocorticoids - New Recognition 
of Our Familiar Friend: Qian X (ed). InTech, pp151-174, 2012. 
10. Rosen dB, Putta S, Covey T, Huang Yw, Nolan GP, Cesano A, 
Minden Md and Fantl wJ: distinct patterns of dNA damage 
response and apoptosis correlate with Jak/Stat and PI3kinase 
response profiles in human acute myelogenous leukemia. PLoS 
One 5: e12405, 2010. 
11. Healy J, Bélanger H, Beaulieu P, Larivière M, Labuda d and 
Sinnett d: Promoter SNPs in G1/S checkpoint regulators 
and their impact on the susceptibility to childhood leukemia. 
Blood 109: 683-692, 2007. 
12. Nicolaides NC, Galata Z, Kino T, Chrousos GP and 
Charmandari E: The human glucocorticoid receptor: Molecular 
basis of biologic function. Steroids 75: 1-12, 2010. 
13. Tome ME, Jaramillo MC and Briehl MM: Hydrogen peroxide 
signaling is required for glucocorticoid-induced apoptosis in 
lymphoma cells. Free Radic Biol Med 51: 2048-2059, 2011. 
14. Zhang J, wang X, Vikash V, Ye Q, wu d, Liu Y and dong w: 
ROS and ROS-mediated cellular signaling. Oxid Med Cell 
Longev 2016: 4350965, 2016. 
15. Burhans wC and Heintz NH: The cell cycle is a redox cycle: 
Linking phase‑specific targets to cell fate. Free Radic Biol Med 47: 
1282-1293, 2009. 
16. Liemburg-Apers dC, willems PH, Koopman wJ and Grefte S: 
Interactions between mitochondrial reactive oxygen species and 
cellular glucose metabolism. Arch Toxicol 89: 1209-1226, 2015. 
17. Tsiotra PC and Tsigos C: Stress, the endoplasmic reticulum, and 
insulin resistance. Ann NY Acad Sci 1083: 63-76, 2006. 
18. Kato H and Nishitoh H: Stress responses from the endoplasmic 
reticulum in cancer. Front Oncol 5: 93, 2015. 
19. Cao SS and Kaufman RJ: Endoplasmic reticulum stress and 
oxidative stress in cell fate decision and human disease. Antioxid 
Redox Signal 21: 396-413, 2014. 
20. Zeeshan HM, Lee GH, Kim HR and Chae HJ: Endoplasmic 
reticulum stress and associated ROS. Int J Mol Sci 17: 327, 2016. 
21. Almanza A, Carlesso A, Chintha C, Creedican S, doultsinos d, 
Leuzzi B, Luís A, McCarthy N, Montibeller L, More S, et al: 
Endoplasmic reticulum stress signalling - from basic mechanisms 
to clinical applications. FEBS J 286: 241-278, 2019. 
22. Llanos-González E, Henares-Chavarino ÁA, Pedrero-Prieto CM, 
García-Carpintero S, Frontiñán-Rubio J, Sancho-Bielsa FJ, 
Alcain FJ, Peinado JR, Rabanal-Ruíz Y and durán-Prado M: 
Interplay between mitochondrial oxidative disorders and proteo-
stasis in Alzheimer's disease. Front Neurosci 13: 1444, 2020.
23. delprat B, Crouzier L, Su TP and Maurice T: At the crossing 
of ER stress and MAMs: A key role of Sigma-1 receptor. 
In: Calcium Signaling. Islam MS (ed). Springer International 
Publishing, Cham, pp699-718, 2020. 
24. Ferro F, Servais S, Besson P, Roger S, dumas JF and Brisson L: 
Autophagy and mitophagy in cancer metabolic remodelling. 
Semin Cell dev Biol 98: 129-138, 2020.
25. Brown MK and Naidoo N: The endoplasmic reticulum stress 
response in aging and age-related diseases. Front Physiol 3: 263, 
2012. 
26. Binder RJ: Functions of heat shock proteins in pathways of the 
innate and adaptive immune system. J Immunol 193: 5765-5771, 
2014. 
27. Merksamer PI and Papa FR: The UPR and cell fate at a glance. 
J Cell Sci 123: 1003-1006, 2010. 
28. Corazzari M, Gagliardi M, Fimia GM and Piacentini M: 
Endoplasmic reticulum stress, unfolded protein response, and 
cancer cell fate. Front Oncol 7: 78, 2017. 
29. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, 
Murakami T, Taniguchi M, Tanii I, Yoshinaga K, et al: Autophagy 
is activated for cell survival after endoplasmic reticulum stress. 
Mol Cell Biol 26: 9220-9231, 2006. 
30. wei Y, Pattingre S, Sinha S, Bassik M and Levine B: 
JNK1-mediated phosphorylation of Bcl-2 regulates star-
vation-induced autophagy. Mol Cell 30: 678-688, 2008. 
31. Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, 
Ogawa S, Kaufman RJ, Kominami E and Momoi T: ER stress 
(PERK/eIF2alpha phosphorylation) mediates the polyglu-
tamine-induced LC3 conversion, an essential step for autophagy 
formation. Cell death differ 14: 230-239, 2007. 
32. Kharabi Masouleh B, Chevet E, Panse J, Jost E, O'dwyer M, 
Bruemmendorf TH and Samali A: drugging the unfolded protein 
response in acute leukemias. J Hematol Oncol 8: 87, 2015. 
33. Sano R and Reed JC: ER stress-induced cell death mechanisms. 
Biochim Biophys Acta 1833: 3460-3470, 2013. 
34. Csordás G, weaver d and Hajnóczky G: Endoplasmic 
reticulum-mitochondrial contactology: Structure and signaling 
functions. Trends Cell Biol 28: 523-540, 2018. 
35. Akl H, Vervloessem T, Kiviluoto S, Bittremieux M, Parys JB, 
de Smedt H and Bultynck G: A dual role for the anti-apoptotic 
Bcl-2 protein in cancer: Mitochondria versus endoplasmic 
reticulum. Biochim Biophys Acta 1843: 2240-2252, 2014. 
36. Hammadi M, Oulidi A, Gackière F, Katsogiannou M, 
Slomianny C, Roudbaraki M, dewailly E, delcourt P, Lepage G, 
Lotteau S, et al: Modulation of ER stress and apoptosis by 
endoplasmic reticulum calcium leak via translocon during 
unfolded protein response: Involvement of GRP78. FASEB J 27: 
1600-1609, 2013. 
37. Xia M, Zhang Y, Jin K, Lu Z, Zeng Z and Xiong w: 
Communication between mitochondria and other organelles: 
A brand-new perspective on mitochondria in cancer. Cell 
Biosci 9: 27, 2019.
38. Kondratskyi A, Kondratska K, Skryma R, Klionsky dJ and 
Prevarskaya N: Ion channels in the regulation of autophagy. 
Autophagy 14: 3-21, 2018. 
39. Sun F, Xu X, wang X and Zhang B: Regulation of autophagy by 
Ca(2). Tumour Biol 37: 15467-15476, 2016. 
40. Bootman Md, Chehab T, Bultynck G, Parys JB and Rietdorf K: 
The regulation of autophagy by calcium signals: do we have a 
consensus? Cell Calcium 70: 32-46, 2018. 
41. Kania E, Pająk B and Orzechowski A: Calcium homeostasis and 
ER stress in control of autophagy in cancer cells. BioMed Res 
Int 2015: 352794, 2015. 
42. Raetz EA and Teachey dT: T-cell acute lymphoblastic leukemia. 
Hematology Am Soc Hematol Educ Program 2016: 580-588, 
2016. 
43. Terwilliger T and Abdul-Hay M: Acute lymphoblastic leukemia: 
A comprehensive review and 2017 update. Blood Cancer J 7: 
e577, 2017. 
44. Irwin ME, Rivera-del Valle N and Chandra J: Redox control of 
leukemia: From molecular mechanisms to therapeutic opportu-
nities. Antioxid Redox Signal 18: 1349-1383, 2013. 
45. Harmon JM and Thompson EB: Isolation and characterization of 
dexamethasone-resistant mutants from human lymphoid cell line 
CEM-C7. Mol Cell Biol 1: 512-521, 1981. 
46. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA and 
McCarthy RE: Continuous culture of human lymphoblasts from 
peripheral blood of a child with acute leukemia. Cancer 18: 
522-529, 1965. 
47. Saenz GJ, Hovanessian R, Gisis Ad and Medh Rd: Glucocorticoid-
mediated co-regulation of RCAN1-1, E4BP4 and BIM in human 
leukemia cells susceptible to apoptosis. Biochem Biophys Res 
Commun 463: 1291-1296, 2015.
48. Jiang L, Xu L, Xie J, Li S, Guan Y, Zhang Y, Hou Z, Guo T, 
Shu X, wang C, et al: Inhibition of autophagy overcomes gluco-
corticoid resistance in lymphoid malignant cells. Cancer Biol 
Ther 16: 466-476, 2015. 
SUdSAwARd et al:  ER STRESS, UPR ANd AUTOPHAGY IN ALL RESISTANCE TO TREATMENT10
49. Norman MR and Thompson EB: Characterization of a gluco-
corticoid-sensitive human lymphoid cell line. Cancer Res 37: 
3785-3791, 1977.
50. Lynch JT, Rajendran R, Xenaki G, Berrou I, demonacos C and 
Krstic-demonacos M: The role of glucocorticoid receptor phos-
phorylation in Mcl-1 and NOXA gene expression. Mol Cancer 9: 
38, 2010. 
51. Qattan MY, Bakker EY, Rajendran R, Chen dw, Saha V, Liu J, 
Zeef L, Schwartz JM, Mutti L, demonacos C, et al: differential 
regulation of cell death pathways by the microenvironment 
correlates with chemoresistance and survival in leukaemia. PLoS 
One 12: e0178606, 2017. 
52. Livak KJ and Schmittgen Td: Analysis of relative gene 
expression data using real-time quantitative PCR and the 2-ΔΔCT 
method. Methods 25: 402-408, 2001.
53. Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema KJ, 
Coppes RP, Engedal N, Mari M and Reggiori F: Chloroquine 
inhibits autophagic flux by decreasing autophagosome‑lysosome 
fusion. Autophagy 14: 1435-1455, 2018. 
54. Sehgal P, Szalai P, Olesen C, Praetorius HA, Nissen P, 
Christensen SB, Engedal N and Møller JV: Inhibition of the 
sarco/endoplasmic reticulum (ER) Ca2+-ATPase by thapsigargin 
analogs induces cell death via ER Ca2+ depletion and the unfolded 
protein response. J Biol Chem 292: 19656-19673, 2017. 
55. Chen Y, McMillan-ward E, Kong J, Israels SJ and Gibson SB: 
Mitochondrial electron-transport-chain inhibitors of complexes I 
and II induce autophagic cell death mediated by reactive oxygen 
species. J Cell Sci 120: 4155-4166, 2007. 
56. Zorova Ld, Popkov VA, Plotnikov EY, Silachev dN, Pevzner IB, 
Jankauskas SS, Babenko VA, Zorov Sd, Balakireva AV, 
Juhaszova M, et al: Mitochondrial membrane potential. Anal 
Biochem 552: 50-59, 2018.
57. wilkinson L, Verhoog NJ and Louw A: disease- and 
treatment-associated acquired glucocorticoid resistance. Endocr 
Connect 7: R328-R349, 2018. 
58. Bakker E, Qattan M, Mutti L, demonacos C and Krstic-
demonacos M: The role of microenvironment and immunity in 
drug response in leukemia. Biochim Biophys Acta 1863: 414-426, 
2016. 
59. djavaheri-Mergny M, Giuriato S, Tschan MP and Humbert M: 
Therapeutic modulation of autophagy in leukaemia and 
lymphoma. Cells 8: E103, 2019. 
60. Pua HH and He Yw: Autophagy and lymphocyte homeostasis. 
Curr Top Microbiol Immunol 335: 85-105, 2009. 
61. Botbol Y, Guerrero-Ros I and Macian F: Key roles of autophagy 
in regulating T-cell function. Eur J Immunol 46: 1326-1334, 2016. 
62. Hotamisligil GS and davis RJ: Cell signaling and stress 
responses. Cold Spring Harb Perspect Biol 8: a006072, 2016. 
63. davies L, Karthikeyan N, Lynch JT, Sial EA, Gkourtsa A, 
demonacos C and Krstic-demonacos M: Cross talk of signaling 
pathways in the regulation of the glucocorticoid receptor 
function. Mol Endocrinol 22: 1331-1344, 2008. 
64. Chen dw, Saha V, Liu JZ, Schwartz JM and Krstic-demonacos M: 
Erg and AP-1 as determinants of glucocorticoid response in 
acute lymphoblastic leukemia. Oncogene 32: 3039-3048, 2013. 
65. Medh Rd, webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, 
wood TG, Luxon BA and Thompson EB: Gene expression 
profile of human lymphoid CEM cells sensitive and resistant to 
glucocorticoid-evoked apoptosis. Genomics 81: 543-555, 2003. 
66. Evangelisti C, Evangelisti C, Chiarini F, Lonetti A, Buontempo F, 
Neri LM, McCubrey JA and Martelli AM: Autophagy in acute 
leukemias: A double-edged sword with important therapeutic 
implications. Biochim Biophys Acta 1853: 14-26, 2015. 
67. Auberger P and Puissant A: Autophagy, a key mechanism of 
oncogenesis and resistance in leukemia. Blood 129: 547-552, 2017. 
68. Takahashi H, Inoue J, Sakaguchi K, Takagi M, Mizutani S 
and Inazawa J: Autophagy is required for cell survival under 
L-asparaginase-induced metabolic stress in acute lymphoblastic 
leukemia cells. Oncogene 36: 4267-4276, 2017. 
69. Rothe K, Porter V and Jiang X: Current outlook on autophagy in 
human leukemia: Foe in cancer stem cells and drug resistance, 
friend in new therapeutic interventions. Int J Mol Sci 20: E461, 
2019. 
70. Laane E, Tamm KP, Buentke E, Ito K, Kharaziha P, Oscarsson J, 
Corcoran M, Björklund AC, Hultenby K, Lundin J, et al: Cell 
death induced by dexamethasone in lymphoid leukemia is 
mediated through initiation of autophagy. Cell death differ 16: 
1018-1029, 2009. 
71. Simioni C, Neri LM, Tabellini G, Ricci F, Bressanin d, Chiarini F, 
Evangelisti C, Cani A, Tazzari PL, Melchionda F, et al: Cytotoxic 
activity of the novel Akt inhibitor, MK-2206, in T-cell acute 
lymphoblastic leukemia. Leukemia 26: 2336-2342, 2012. 
72. Verfaillie T, Salazar M, Velasco G, Agostinis P and Linking ER: 
Linking ER stress to autophagy: Potential implications for cancer 
therapy. Int J Cell Biol 2010: 930509, 2010. 
73. Martinvalet d: The role of the mitochondria and the endoplasmic 
reticulum contact sites in the development of the immune 
responses. Cell death dis 9: 336, 2018.
74. dengler MA, Staiger AM, Gutekunst M, Hofmann U, doszczak M, 
Scheurich P, Schwab M, Aulitzky wE and van der Kuip H: 
Oncogenic stress induced by acute hyper-activation of Bcr-Abl 
leads to cell death upon induction of excessive aerobic glycolysis. 
PLoS One 6: e25139, 2011. 
75. Lee AS: Glucose-regulated proteins in cancer: Molecular mech-
anisms and therapeutic potential. Nat Rev Cancer 14: 263-276, 
2014. 
76. Biswas C, Sriram U, Ciric B, Ostrovsky O, Gallucci S and 
Argon Y: The N‑terminal fragment of GRP94 is sufficient for 
peptide presentation via professional antigen-presenting cells. Int 
Immunol 18: 1147-1157, 2006. 
77. Ansa-Addo EA, Thaxton J, Hong F, wu BX, Zhang Y, Fugle Cw, 
Metelli A, Riesenberg B, williams K, Gewirth dT, et al: Clients 
and oncogenic roles of molecular chaperone gp96/grp94. Curr 
Top Med Chem 16: 2765-2778, 2016. 
78. duan XF and Xin Yw: Overexpression of molecule GRP94 
favors tumor progression in lung adenocarcinoma by interaction 
with regulatory T cells. Thorac Cancer 11: 704-712, 2020. 
79. wiersma VR, Michalak M, Abdullah TM, Bremer E and 
Eggleton P: Mechanisms of translocation of ER chaperones to the 
cell surface and immunomodulatory roles in cancer and autoim-
munity. Front Oncol 5: 7, 2015. 
80. Binder RJ. Immunosurveillance of cancer and the heat shock 
protein-Cd91 pathway. Cell Immunol 343: 103814, 2019.
81. Sundman-Engberg B, Tidefelt U, Gruber A and Paul C: 
Intracellular concentrations of mitoxantrone in leukemic cells 
in vitro vs. in vivo. Leuk Res 17: 347-52, 1993.
